shortagewatch

Home / Simvastatin and Ezetimibe / Czechia

CZ ATC C10BA02 · updated 2 Nov 2026

Simvastatin and Ezetimibe shortage in Czechia

Is there a Simvastatin and Ezetimibe shortage in Czechia?

Yes. As of 2 Nov 2026, 7 Simvastatin and Ezetimibe products are reported short in Czechia, the first since 19 Mar 2025. The company estimate for the return is 30 Nov 2026 (latest 1 Nov 2027). Main reason: manufacturing problem.

Also short in Germany, Italy, Spain, Ireland, Belgium, Sweden, New Zealand. All countries.

Affected products in Czechia

CountryProductCompanySinceExpected backReason
CZEZETIMIBE/SIMVASTATIN TEVA CR 10MG/20MG 10MG/20MG TBL NOB 30Teva Pharmaceuticals CR, s.r.o., Praha19 Mar 202531 Oct 2027Manufacturing problem
Výrobní důvody
CZGLEZISIM 10MG/20MG 10MG/20MG TBL NOB 84Glenmark Pharmaceuticals s.r.o., Praha1 Mar 20261 Nov 2027Commercial decision or withdrawal
Obchodní/marketingové důvody
CZGLEZISIM 10MG/40MG 10MG/40MG TBL NOB 84Glenmark Pharmaceuticals s.r.o., Praha1 Mar 20261 Nov 2027Commercial decision or withdrawal
Obchodní/marketingové důvody
CZEZETIMIBE/SIMVASTATIN TEVA CR 10MG/20MG 10MG/20MG TBL NOB 28Teva Pharmaceuticals CR, s.r.o., Praha18 May 202630 Nov 2026Manufacturing problem
Výrobní důvody
CZEZETIMIBE/SIMVASTATIN TEVA CR 10MG/20MG 10MG/20MG TBL NOB 98Teva Pharmaceuticals CR, s.r.o., Praha9 Jul 202630 Nov 2026Manufacturing problem
Výrobní důvody
CZEZETIMIBE/SIMVASTATIN TEVA CR 10MG/20MG 10MG/20MG TBL NOB 100Teva Pharmaceuticals CR, s.r.o., Praha21 Oct 202631 Oct 2027Commercial decision or withdrawal
Obchodní/marketingové důvody
CZEZETIMIBE/SIMVASTATIN TEVA CR 10MG/10MG 10MG/10MG TBL NOB 28 anticipatedTeva Pharmaceuticals CR, s.r.o., Praha11 Dec 202628 Feb 2027Manufacturing problem
Výrobní důvody

Source

SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.